NCT03420963 2026-03-03Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled
NCT06336148 2025-10-15A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsActym Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT02628535 2022-02-08Safety Study of MGD009 in B7-H3-expressing TumorsMacroGenicsPhase 1 Terminated67 enrolled